Institute of Pharmacology, Catholic University of Sacred Heart, Rome, Italy.
Eur J Pain. 2012 Sep;16(8):1148-57. doi: 10.1002/j.1532-2149.2012.00122.x. Epub 2012 Mar 6.
Gamma-aminobutyric acid (GABA) and glutamate (GLU) are involved in nociceptive signals processing in the trigeminal system. In this study, we investigated the influence of excitatory transmission on GABA release in nerve terminals isolated from the rat trigeminal caudal nucleus (TCN).
We utilize biochemical (superfused synaptosomes loaded with [(3) H]GABA) and morphological (immunofluorescence experiments with specific antibody) techniques.
Our results show that GLU potentiates the release of [(3) H]GABA evoked by 9, 15 and 30 mM K(+); 15 mM K(+)-evoked [(3) H]GABA release was also reinforced by domoate and kainate (KA), two naturally occurring GLU-receptor agonists. The enhancement of 15 mM K(+)-evoked [(3) H]GABA release produced by 100 μM KA was abolished by NBQX, a mixed AMPA/KA receptor antagonist, but was not affected by GYKI52466, a selective AMPA receptor antagonist. ATPA, a selective agonist for KA receptors containing the GLUK1 subunit, had no effect on depolarization-induced [(3) H]GABA release, and UBP310, which selectively antagonizes these same receptors, failed to reverse the KA-induced potentiation of 15 mM K(+)-evoked [(3) H]GABA release. The KA-induced potentiation was also unaffected by concanavalin A (10 μM), a positive allosteric modulator of GLUK1- and GLUK2-containing KA receptors. Immunofluorescence experiments revealed that GABAergic nerve terminals in the TCN differentially expressed GLUK subunits, with GLUK2/3-positive terminals being twice more abundant than GLUK1-containing synaptosomes.
These findings indicate that pre-synaptic KA receptors facilitating GABA release from TCN nerve terminals mainly express GLUK2/GLUK3 subunits, supporting the notion that different types of KA receptors are involved in the various stages of pain transmission.
γ-氨基丁酸(GABA)和谷氨酸(GLU)参与三叉神经系统中的伤害性信号处理。在这项研究中,我们研究了兴奋传递对大鼠三叉神经尾核(TCN)神经末梢 GABA 释放的影响。
我们利用生物化学(用 [(3)H]GABA 标记的超滤液突触小体)和形态学(用特异性抗体的免疫荧光实验)技术。
我们的结果表明,GLU 增强了 9、15 和 30 mM [K(+)](e)诱发的 [(3)H]GABA 的释放;15 mM [K(+)](e)诱发的 [(3)H]GABA 释放也被两种天然存在的 GLU 受体激动剂,即 二酸和海人藻酸(KA)增强。100 μM KA 对 15 mM [K(+)](e)诱发的 [(3)H]GABA 释放的增强作用被 NBQX 消除,NBQX 是一种混合 AMPA/KA 受体拮抗剂,但不受 GYKI52466 的影响,GYKI52466 是一种选择性 AMPA 受体拮抗剂。ATPA,一种含有 GLUK1 亚基的 KA 受体的选择性激动剂,对去极化诱导的 [(3)H]GABA 释放没有影响,而 UBP310,它选择性地拮抗这些相同的受体,未能逆转 KA 诱导的 15 mM [K(+)](e)诱发的 [(3)H]GABA 释放的增强作用。KA 诱导的增强作用也不受伴刀豆球蛋白 A(10 μM)的影响,伴刀豆球蛋白 A 是 GLUK1 和 GLUK2 含有 KA 受体的正变构调节剂。免疫荧光实验表明,TCN 中的 GABA 能神经末梢差异表达 GLUK 亚单位,GLUK2/3 阳性末梢的数量是 GLUK1 阳性突触小体的两倍。
这些发现表明,TCN 神经末梢的前突触 KA 受体促进 GABA 释放,主要表达 GLUK2/GLUK3 亚单位,支持不同类型的 KA 受体参与疼痛传递的不同阶段的观点。